ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $93,000 | -66.3% | 17,561 | -69.5% | 0.00% | -100.0% |
| Q1 2021 | $276,000 | +60.5% | 57,484 | +44.4% | 0.00% | +100.0% |
| Q4 2020 | $172,000 | -49.3% | 39,822 | -51.7% | 0.00% | -80.0% |
| Q3 2020 | $339,000 | +1203.8% | 82,363 | +721.4% | 0.01% | – |
| Q2 2020 | $26,000 | -77.2% | 10,027 | -66.8% | 0.00% | -100.0% |
| Q4 2019 | $114,000 | -7.3% | 30,177 | +52.4% | 0.00% | 0.0% |
| Q2 2019 | $123,000 | -41.7% | 19,803 | -19.9% | 0.00% | -50.0% |
| Q4 2018 | $211,000 | -79.9% | 24,720 | -52.8% | 0.00% | -84.6% |
| Q3 2018 | $1,049,000 | -68.7% | 52,400 | -59.7% | 0.01% | -70.5% |
| Q2 2018 | $3,355,000 | +301.3% | 129,874 | +271.2% | 0.04% | +238.5% |
| Q1 2018 | $836,000 | +8.0% | 34,992 | +53.3% | 0.01% | 0.0% |
| Q4 2017 | $774,000 | +223.8% | 22,828 | +102.1% | 0.01% | +160.0% |
| Q3 2017 | $239,000 | – | 11,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |